Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes
about
Aripiprazole versus haloperidol for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus sulpiride for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus perphenazine for people with schizophrenia and schizophrenia-like psychosesAripiprazole for neuroleptic induced hyperprolactinaemiaAripiprazole dose for schizophreniaAntipsychotic drug treatment for elderly people with late-onset schizophreniaTherapeutic potential for novel drugs targeting the type 1 cholecystokinin receptorSerotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disordersTargeting G protein coupled receptor-related pathways as emerging molecular therapiesMismatch negativity: translating the potentialDopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?Biophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug DesignCOMT val158met moderation of dopaminergic drug effects on cognitive function: a critical reviewUpdate on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismUnique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in RatsA simple method for quantifying functional selectivity and agonist biasSKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase CThe 5-HT7 receptor and disorders of the nervous system: an overview.Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in ratsAripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humansClassics in Chemical Neuroscience: Aripiprazole.Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.Open labeled, randomized, switch-over study of two fixed doses (10/15mg) of aripiprazole : to evaluate its safety and efficacy in the treatment of Indian patients of schizophreniaDiscovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability.Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.The potential for selective pharmacological therapies through biased receptor signalingAripiprazole: a new atypical antipsychotic drug.Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers.Aripiprazole: pharmacology, efficacy, safety and tolerability.Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders.New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signalingPharmGKB summary: dopamine receptor D2Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapseAripiprazole: a partial dopamine D2 receptor agonist antipsychotic.Aripiprazole maintenance increases smoked cocaine self-administration in humans.
P2860
Q24186218-AF6F5CE3-A94F-4CE9-8A62-CA4C4A503C30Q24186219-E0FE2E3A-1566-4B90-9DF0-87C71233F962Q24186220-EF8A2DDB-CD49-4C6E-8F80-6100E7A336D6Q24186223-0FD489B7-EB91-4F33-95D3-AF72CEB316DCQ24197806-79259D00-D5C2-4834-8187-2BE177D26433Q24200753-7F5251ED-E4C1-4023-A229-634AE6ABF204Q24203649-93351E7E-6505-4801-B839-D2744EC5A654Q24628602-CED168EF-1601-406C-B6F8-EFA8ADF54245Q24632508-3DFFB936-05C3-495F-9E6E-3F7B6D9FECB3Q26829964-4FD5713B-8697-4F7B-A237-77D2A38D6B49Q26830827-D8D5523A-7A32-44D6-AAAE-16EDAA6384DEQ26864383-BC48D29D-5BC5-4C52-A2F3-7107F046042CQ27676919-C6CA9EC1-94FB-4C66-8B7E-98277678C279Q28074860-33CCC76F-EB96-4D45-B7FF-1FDC027FC3DAQ28084069-A99AA461-C31B-4772-AA0C-F90EA8244EAEQ28546441-BE339E55-7ECF-4420-B829-6DCE68700B94Q28728741-10EFA9DF-B696-4E3E-B1DC-448822D90440Q30400003-3DFECDCD-83E6-4A86-B079-BDB3F406BF1AQ33738349-D579788B-1E51-479E-867A-A1D1FE805CB5Q33748306-B2C9AFA8-3610-49A7-8508-27386DE790E6Q33841432-7EBB7E47-19B1-47BD-BDE4-EFDC1523AC8EQ33866125-65BAB361-DCCF-405A-A1A1-6459452FF193Q33890786-F6F50C9B-ED9E-476E-B30D-0FA626C61241Q33966353-984F2A58-080F-4758-A9E6-8FA28042EC5BQ34013720-8B03248E-9813-463B-AF6A-207EB03049D9Q34030668-7146E6AF-D8C0-4E70-B576-5BCCC1A7DED8Q34227284-36835675-B44E-47E4-ABEB-772073DB31F7Q34322714-29ECB1D0-3A83-4370-968D-E92170176249Q34338202-9FA92B59-E513-4A18-9575-378BBE205129Q34402658-19A8F6E3-AA0D-4416-90CA-F9B18882879BQ34533055-02BA19EC-8C9A-4D17-9FFC-5687F06F537DQ34544811-705E4611-0337-44A1-9563-3BA7E0CD7FA1Q34558285-1A4EB810-A689-4AE5-A34D-6F858AE4798AQ34613057-14FC8F59-B4B1-459E-838D-4682737546D2Q34772251-5D5F3442-BC26-4DEC-91BC-D1EDF55644A7Q34970259-CAA0CBFD-6646-4345-A2E0-093AA71761EEQ35012574-FFEE6CEE-82E3-4D4B-B6AC-6BB3E4570B7FQ35062881-FAAD4117-312F-4E09-895A-051E7364A982Q35094691-5BDFE58A-DD29-4D99-9D28-88BCCB1A11E0Q35098039-E83DFED2-7F96-462F-94D7-AEB780333BBA
P2860
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Interactions of the novel anti ...... nd serotonin receptor subtypes
@ast
Interactions of the novel anti ...... nd serotonin receptor subtypes
@en
Interactions of the novel anti ...... nd serotonin receptor subtypes
@nl
type
label
Interactions of the novel anti ...... nd serotonin receptor subtypes
@ast
Interactions of the novel anti ...... nd serotonin receptor subtypes
@en
Interactions of the novel anti ...... nd serotonin receptor subtypes
@nl
prefLabel
Interactions of the novel anti ...... nd serotonin receptor subtypes
@ast
Interactions of the novel anti ...... nd serotonin receptor subtypes
@en
Interactions of the novel anti ...... nd serotonin receptor subtypes
@nl
P2093
P3181
P1476
Interactions of the novel anti ...... nd serotonin receptor subtypes
@en
P2093
A M Gonzalez
C P Lawler
C Prioleau
D R Sibley
J A Schetz
R B Mailman
P304
P3181
P356
10.1016/S0893-133X(98)00099-2
P407
P577
1999-06-01T00:00:00Z
P6179
1002635243